Logo image of LILAK

LIBERTY LATIN AMERIC-CL C (LILAK) Stock Fundamental Analysis

NASDAQ:LILAK - Nasdaq - BMG9001E1286 - Common Stock - Currency: USD

7.98  -0.01 (-0.13%)

After market: 7.98 0 (0%)

Fundamental Rating

3

LILAK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 35 industry peers in the Diversified Telecommunication Services industry. While LILAK is still in line with the averages on profitability rating, there are concerns on its financial health. LILAK has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year LILAK has reported negative net income.
LILAK had a positive operating cash flow in the past year.
LILAK had negative earnings in each of the past 5 years.
LILAK had a positive operating cash flow in each of the past 5 years.
LILAK Yearly Net Income VS EBIT VS OCF VS FCFLILAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

LILAK's Return On Assets of -6.29% is on the low side compared to the rest of the industry. LILAK is outperformed by 85.71% of its industry peers.
The Return On Equity of LILAK (-77.60%) is worse than 82.86% of its industry peers.
With a decent Return On Invested Capital value of 4.33%, LILAK is doing good in the industry, outperforming 62.86% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for LILAK is below the industry average of 7.11%.
The 3 year average ROIC (4.30%) for LILAK is below the current ROIC(4.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -6.29%
ROE -77.6%
ROIC 4.33%
ROA(3y)-2.32%
ROA(5y)-2.88%
ROE(3y)-23.98%
ROE(5y)-23.6%
ROIC(3y)4.3%
ROIC(5y)3.96%
LILAK Yearly ROA, ROE, ROICLILAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

LILAK has a Operating Margin of 13.19%. This is in the better half of the industry: LILAK outperforms 62.86% of its industry peers.
In the last couple of years the Operating Margin of LILAK has declined.
LILAK has a Gross Margin of 77.89%. This is amongst the best in the industry. LILAK outperforms 94.29% of its industry peers.
LILAK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.19%
PM (TTM) N/A
GM 77.89%
OM growth 3Y-7.22%
OM growth 5Y-4.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y0.13%
LILAK Yearly Profit, Operating, Gross MarginsLILAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

2

2. Health

2.1 Basic Checks

LILAK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
LILAK has less shares outstanding than it did 1 year ago.
LILAK has more shares outstanding than it did 5 years ago.
The debt/assets ratio for LILAK is higher compared to a year ago.
LILAK Yearly Shares OutstandingLILAK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
LILAK Yearly Total Debt VS Total AssetsLILAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.19, we must say that LILAK is in the distress zone and has some risk of bankruptcy.
LILAK has a Altman-Z score of 0.19. This is in the lower half of the industry: LILAK underperforms 68.57% of its industry peers.
LILAK has a debt to FCF ratio of 35.50. This is a negative value and a sign of low solvency as LILAK would need 35.50 years to pay back of all of its debts.
With a Debt to FCF ratio value of 35.50, LILAK is not doing good in the industry: 62.86% of the companies in the same industry are doing better.
A Debt/Equity ratio of 7.47 is on the high side and indicates that LILAK has dependencies on debt financing.
LILAK has a worse Debt to Equity ratio (7.47) than 82.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.47
Debt/FCF 35.5
Altman-Z 0.19
ROIC/WACC0.62
WACC7.02%
LILAK Yearly LT Debt VS Equity VS FCFLILAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

LILAK has a Current Ratio of 1.08. This is a normal value and indicates that LILAK is financially healthy and should not expect problems in meeting its short term obligations.
LILAK has a Current ratio (1.08) which is in line with its industry peers.
LILAK has a Quick Ratio of 1.08. This is a normal value and indicates that LILAK is financially healthy and should not expect problems in meeting its short term obligations.
LILAK's Quick ratio of 1.08 is in line compared to the rest of the industry. LILAK outperforms 57.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08
LILAK Yearly Current Assets VS Current LiabilitesLILAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

LILAK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1346.34%.
Looking at the last year, LILAK shows a decrease in Revenue. The Revenue has decreased by -1.20% in the last year.
The Revenue has been growing slightly by 2.88% on average over the past years.
EPS 1Y (TTM)-1346.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-863.64%
Revenue 1Y (TTM)-1.2%
Revenue growth 3Y-2.54%
Revenue growth 5Y2.88%
Sales Q2Q%-2.8%

3.2 Future

The Earnings Per Share is expected to grow by 27.00% on average over the next years. This is a very strong growth
Based on estimates for the next years, LILAK will show a small growth in Revenue. The Revenue will grow by 2.60% on average per year.
EPS Next Y83.43%
EPS Next 2Y45.01%
EPS Next 3Y30.42%
EPS Next 5Y27%
Revenue Next Year-0.5%
Revenue Next 2Y1.3%
Revenue Next 3Y1.98%
Revenue Next 5Y2.6%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
LILAK Yearly Revenue VS EstimatesLILAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
LILAK Yearly EPS VS EstimatesLILAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2 -3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LILAK. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 23.24, the valuation of LILAK can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as LILAK.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.04, LILAK is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 23.24
LILAK Price Earnings VS Forward Price EarningsLILAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

LILAK's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. LILAK is cheaper than 85.71% of the companies in the same industry.
77.14% of the companies in the same industry are more expensive than LILAK, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.93
EV/EBITDA 5.99
LILAK Per share dataLILAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

LILAK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LILAK's earnings are expected to grow with 30.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.01%
EPS Next 3Y30.42%

0

5. Dividend

5.1 Amount

LILAK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LIBERTY LATIN AMERIC-CL C

NASDAQ:LILAK (8/8/2025, 8:00:02 PM)

After market: 7.98 0 (0%)

7.98

-0.01 (-0.13%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners65.42%
Inst Owner Change-2.21%
Ins Owners11.61%
Ins Owner ChangeN/A
Market Cap1.60B
Analysts76
Price Target7.86 (-1.5%)
Short Float %15.19%
Short Ratio3.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1197.36%
Min EPS beat(2)-1558.43%
Max EPS beat(2)-836.29%
EPS beat(4)0
Avg EPS beat(4)-10460.5%
Min EPS beat(4)-28858.2%
Max EPS beat(4)-836.29%
EPS beat(8)3
Avg EPS beat(8)-5243.52%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-4.03%
Max Revenue beat(2)-1.09%
Revenue beat(4)0
Avg Revenue beat(4)-3.42%
Min Revenue beat(4)-5.29%
Max Revenue beat(4)-1.09%
Revenue beat(8)0
Avg Revenue beat(8)-3.19%
Revenue beat(12)0
Avg Revenue beat(12)-3.11%
Revenue beat(16)1
Avg Revenue beat(16)-2.37%
PT rev (1m)-0.39%
PT rev (3m)2.72%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)-373.68%
EPS NY rev (1m)0%
EPS NY rev (3m)-1070.95%
Revenue NQ rev (1m)-2%
Revenue NQ rev (3m)-2.43%
Revenue NY rev (1m)-0.55%
Revenue NY rev (3m)-2.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.24
P/S 0.36
P/FCF 6.93
P/OCF 2.11
P/B 1.56
P/tB N/A
EV/EBITDA 5.99
EPS(TTM)-5.93
EYN/A
EPS(NY)0.34
Fwd EY4.3%
FCF(TTM)1.15
FCFY14.43%
OCF(TTM)3.79
OCFY47.49%
SpS22.22
BVpS5.11
TBVpS-20.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.29%
ROE -77.6%
ROCE 5.48%
ROIC 4.33%
ROICexc 4.58%
ROICexgc 9.41%
OM 13.19%
PM (TTM) N/A
GM 77.89%
FCFM 5.18%
ROA(3y)-2.32%
ROA(5y)-2.88%
ROE(3y)-23.98%
ROE(5y)-23.6%
ROIC(3y)4.3%
ROIC(5y)3.96%
ROICexc(3y)4.63%
ROICexc(5y)4.26%
ROICexgc(3y)9.72%
ROICexgc(5y)8.98%
ROCE(3y)5.45%
ROCE(5y)5.02%
ROICexcg growth 3Y-0.27%
ROICexcg growth 5Y1.35%
ROICexc growth 3Y-1.91%
ROICexc growth 5Y1.9%
OM growth 3Y-7.22%
OM growth 5Y-4.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 7.47
Debt/FCF 35.5
Debt/EBITDA 4.97
Cap/Depr 55.56%
Cap/Sales 11.88%
Interest Coverage 1.01
Cash Conversion 49.35%
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z 0.19
F-Score5
WACC7.02%
ROIC/WACC0.62
Cap/Depr(3y)62.1%
Cap/Depr(5y)64.9%
Cap/Sales(3y)12.93%
Cap/Sales(5y)13.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1346.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-863.64%
EPS Next Y83.43%
EPS Next 2Y45.01%
EPS Next 3Y30.42%
EPS Next 5Y27%
Revenue 1Y (TTM)-1.2%
Revenue growth 3Y-2.54%
Revenue growth 5Y2.88%
Sales Q2Q%-2.8%
Revenue Next Year-0.5%
Revenue Next 2Y1.3%
Revenue Next 3Y1.98%
Revenue Next 5Y2.6%
EBIT growth 1Y4.36%
EBIT growth 3Y-9.58%
EBIT growth 5Y-1.84%
EBIT Next Year876.12%
EBIT Next 3Y118.64%
EBIT Next 5Y85.12%
FCF growth 1Y15.45%
FCF growth 3Y-8.29%
FCF growth 5Y-8.09%
OCF growth 1Y-6.34%
OCF growth 3Y-9.38%
OCF growth 5Y-3.81%